IMPACT OF CIRRHOSIS SEVERITY ON SURVIVAL IN HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Driver, Robert [1 ]
Chizhande, David [1 ]
Jones, Rebecca [1 ]
Rowe, Ian [1 ]
机构：
[1] Leeds Teaching Hosp, Leeds, W Yorkshire, England
来源：
GUT | 2018年 / 67卷
关键词：
D O I：
10.1136/gutjnl-2018-BSGAbstracts.218
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PWE-076
引用
收藏
页码：A110 / A110
页数：1
相关论文
共 50 条
  • [21] Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients
    Feder, Susanne
    Haberl, Elisabeth M.
    Spirk, Marlen
    Weiss, Thomas S.
    Wiest, Reiner
    Buechler, Christa
    CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 20 (02) : 289 - 297
  • [22] Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening
    Simao, Adelia
    Madaleno, Joao
    Silva, Nuno
    Rodrigues, Fernando
    Caseiro, Paula
    Costa, Jose Nascimento
    Carvalho, Armando
    BMC GASTROENTEROLOGY, 2015, 15
  • [23] Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
    Inghilesi, Andrea L.
    Gallori, Donatella
    Antonuzzo, Lorenzo
    Forte, Paolo
    Tomcikova, Daniela
    Arena, Umberto
    Colagrande, Stefano
    Pradella, Silvia
    Fani, Bernardo
    Gianni, Elena
    Boni, Luca
    Laffi, Giacomo
    Di Costanzo, Francesco
    Marra, Fabio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (03) : 786 - 794
  • [24] Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis
    Kitai, Satoshi
    Kudo, Masatoshi
    Nishida, Naoshi
    Izumi, Namiki
    Sakamoto, Michiie
    Matsuyama, Yutaka
    Ichida, Takafumi
    Nakashima, Osamu
    Matsui, Osamu
    Ku, Yonson
    Kokudo, Norihiro
    Makuuchi, Masatoshi
    LIVER CANCER, 2016, 5 (03) : 175 - 189
  • [25] Screening for hepatocellular carcinoma in cirrhosis leads to early diagnosis and improved survival
    Farinata, F
    Rinaldi, M
    Vian, A
    Foschia, F
    Chiaramonte, M
    Naccarato, R
    GUT, 1997, 41 : A231 - A231
  • [26] Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
    Andrea L Inghilesi
    Donatella Gallori
    Lorenzo Antonuzzo
    Paolo Forte
    Daniela Tomcikova
    Umberto Arena
    Stefano Colagrande
    Silvia Pradella
    Bernardo Fani
    Elena Gianni
    Luca Boni
    Giacomo Laffi
    Francesco Di Costanzo
    Fabio Marra
    World Journal of Gastroenterology, 2014, 20 (03) : 786 - 794
  • [27] Impact of Cirrhosis on the Choice of Liver Resection in Patients with Hepatocellular Carcinoma
    Zeindler, J.
    Hess, G. F.
    von Heesen, M.
    Aegerter, N.
    Reber, C.
    Schmitt, A.
    Muenst, S.
    Bolli, M.
    Soysal, S. D.
    Kollmar, O.
    BRITISH JOURNAL OF SURGERY, 2023, 110 (SUPP 5) : V5 - V5
  • [28] THE IMPACT OF SOCIOECONOMIC STATUS ON CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN THE UNITED STATES
    Nsenga, Roselyn
    Tzavaras, Sophia
    Waldo, Daniel
    Singal, Amit G.
    Tapper, Elliot B.
    Parikh, Neehar D.
    HEPATOLOGY, 2019, 70 : 387A - 388A
  • [29] Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients
    Susanne Feder
    Elisabeth M. Haberl
    Marlen Spirk
    Thomas S. Weiss
    Reiner Wiest
    Christa Buechler
    Clinical and Experimental Medicine, 2020, 20 : 289 - 297
  • [30] Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma
    Makol, Ankita
    Kanthaje, Shruthi
    Dhiman, Radha K.
    Kalra, Naveen
    Chawla, Yogesh K.
    Chakraborti, Anuradha
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2018, 243 (04) : 323 - 326
12345